Compulsory licences for direct acting antiviral drugs for hepatitis C
| Autor: | Gavino Maciocco, Adriano Cattaneo |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
medicine.medical_specialty
Sofosbuvir Hepatitis C virus medicine.disease_cause Antiviral Agents 01 natural sciences 03 medical and health sciences 0302 clinical medicine medicine Humans 030212 general & internal medicine 0101 mathematics Licensure business.industry 010102 general mathematics General Medicine Hepatitis C Legislation Drug medicine.disease Virology Italy Family medicine Christian ministry business Direct acting medicine.drug |
| Zdroj: | BMJ. :i5314 |
| ISSN: | 1756-1833 |
| DOI: | 10.1136/bmj.i5314 |
| Popis: | In Italy, the decision to ration treatment with direct acting drugs against hepatitis C virus was taken behind closed doors by the Ministry of Health. A 12 week course of treatment with sofosbuvir costs €41 000 (£35 500; $46 000), and the ministry has so far authorised 55 000 treatments—about 5% of the estimated need. The reason … |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|